Summary by Moomoo AI
EC Healthcare announced on 6 February 2024 that it had granted a waiver to send detailed circulars to shareholders due to the additional time required to prepare financial and other information related to the acquisition of the additional interests in New Asia. The acquisition constitutes a major transaction under Chapter 14 of the Listing Rules and the original circular was sent on or before 25 January 2024. Under the exemption, the new deadline for circulars to be sent is 28 March 2024 on or before. If the company's situation changes, the exchange may withdraw or amend this exemption. The Executive Directors of Cixi Health include Mr. Tang Chi-hui, Mr. Lu Lien Wai and Mr. Li Sung Wing. The Non-Executive Director is Mr. Lu Yun-sheng. The Independent Non-Executive Directors include Mr. Ma Ching Nan, Mr. Lu Dong and Mr. Wu Chun.